Obesity and COVID-19: What are the Consequences?

Abstract

Obesity is an increasing health problem all over the world. In combination with the current COVID-19 pandemic, this has turned into a massive challenge as individuals with overweight and obesity at all ages show a significant increase in their risk of getting severe COVID-19. Around 20% of all patients that were hospitalized for COVID-19 suffered from obesity alone, whereas obesity in combination with other metabolic comorbidities, such as type 2 diabetes and hypertension, account for up to 60% of all hospitalizations in relation to COVID-19. Therefore, it is of immense importance to put the spotlight on the high incidence of obesity present already in childhood both by changing the individual minds and by encouraging politicians and the whole society to commence preventive interventions for achieving a better nutrition for all social classes all over the world. In the current review, we aim to explain the different pathways and mechanisms that are responsible for the increased risk of severe COVID-19 in people with overweight and obesity. Furthermore, we discuss how the pandemic has led to weight gains in many people during lockdown. At the end, we discuss the importance of preventing such an interface between a non-communicable disease like obesity and a communicable disease like COVID-19 in the future.

Key words

obesity - metabolic syndrome - COVID-19 - long-COVID - inflammation

Publication History

Received: 16 March 2022

Accepted after revision: 04 April 2022

Accepted Manuscript online:
20 June 2022

Article published online:
09 August 2022

• References

• 1 Steenblock C, Schwarz PEH, Ludwig B. et al. COVID-19 and metabolic disease: mechanisms and clinical management. Lancet Diabetes Endocrinol 2021; 9: 786-798
• 2 O’Hearn M, Liu J, Cudhea F. et al. Coronavirus disease 2019 hospitalizations attributable to cardiometabolic conditions in the United States: a comparative risk assessment analysis. J Am Heart Assoc 2021; 10: e019259
• 3 Goossens GH, Dicker D, Farpour-Lambert NJ. et al. Obesity and COVID-19: a perspective from the European association for the study of obesity on immunological perturbations, therapeutic challenges, and opportunities in obesity. Obes Facts 2020; 13: 439-452
• 4 Discacciati MG, Siani S, Campa A. et al. Why should obese youth be prioritized in COVID-19 vaccination programs? A nationwide retrospective study. Lancet Reg Health Am 2022; 7: 100167
• 5 Onder G, Palmieri L, Vanacore N. et al. Nonrespiratory complications and obesity in patients dying with COVID-19 in Italy. Obesity (Silver Spring) 2021; 29: 20-23
• 6 Tsankov BK, Allaire JM, Irvine MA. et al. Severe COVID-19 infection and pediatric comorbidities: a systematic review and meta-analysis. Int J Infect Dis 2021; 103: 246-256
• 7 Hoste L, Van Paemel R, Haerynck F. Multisystem inflammatory syndrome in children related to COVID-19: a systematic review. Eur J Pediatr 2021; 180: 2019-2034
• 8 World Health Organisation WHO. Obesity and overweight. In:. https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight 2022
• 9 Sattar N, McInnes IB, McMurray JJV. Obesity is a risk factor for severe COVID-19 infection: multiple potential mechanisms. Circulation 2020; 142: 4-6
• 10 Sudhakar M, Winfred SB, Meiyazhagan G. et al. Mechanisms contributing to adverse outcomes of COVID-19 in obesity. Mol Cell Biochem 2022; 477: 1155-1193
• 11 Yu L, Zhang X, Ye S. et al. Obesity and COVID-19: mechanistic insights from adipose tissue. J Clin Endocrinol Metab 2022; 107: 1799-1811
• 12 Sudhakar M, Winfred SB, Meiyazhagan G. et al. Mechanisms contributing to adverse outcomes of COVID-19 in obesity. Mol Cell Biochem 2022; 477: 1155-1193
• 13 Tilg H, Moschen AR. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 2006; 6: 772-783
• 14 Hornung F, Rogal J, Loskill P. et al. The inflammatory profile of obesity and the role on pulmonary bacterial and viral infections. Int J Mol Sci 2021; 22: 3456
• 15 Koch CA, Sharda P, Patel J. et al. Climate change and obesity. Horm Metab Res 2021; 53: 575-587
• 16 Turner JB, Kumar A, Koch CA. The effects of indoor and outdoor temperature on metabolic rate and adipose tissue – the Mississippi perspective on the obesity epidemic. Rev Endocr Metab Disord 2016; 17: 61-71
• 17 Karastergiou K, Fried SK. Cellular mechanisms driving sex differences in adipose tissue biology and body shape in humans and mouse models. Adv Exp Med Biol 2017; 1043: 29-51
• 18 Calle EE, Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 2004; 4: 579-591
• 19 Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes. J Clin Invest 2005; 115: 1111-1119
• 20 VdO Leal, Mafra D. Adipokines in obesity. Clinica Chimica Acta 2013; 419: 87-94
• 21 Cawthorn WP, Scheller EL, Learman BS. et al. Bone marrow adipose tissue is an endocrine organ that contributes to increased circulating adiponectin during caloric restriction. Cell Metab 2014; 20: 368-375
• 22 Bajzová M, Kováciková M, Vítková M. et al. Retinol-binding protein 4 expression in visceral and subcutaneous fat in human obesity. Physiol Res/Acad Sci Bohem 2008; 57: 927-934
• 23 Zha JM, Di WJ, Zhu T. et al. Comparison of gene transcription between subcutaneous and visceral adipose tissue in Chinese adults. Endocr J 2009; 56: 935-944
• 24 Vijay J, Gauthier MF, Biswell RL. et al. Single-cell analysis of human adipose tissue identifies depot and disease specific cell types. Nat Metab 2020; 2: 97-109
• 25 Gordon S, Taylor PR. Monocyte and macrophage heterogeneity. Nat Rev Immunol 2005; 5: 953-964
• 26 Mantovani A, Sica A, Sozzani S. et al. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 2004; 25: 677-686
• 27 Lumeng CN, Bodzin JL, Saltiel AR. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest 2007; 117: 175-184
• 28 Hill DA, Lim HW, Kim YH. et al. Distinct macrophage populations direct inflammatory versus physiological changes in adipose tissue. Proc Natl Acad Sci U S A 2018; 115: E5096-E5105
• 29 Oz M, Lorke DE. Multifunctional angiotensin converting enzyme 2, the SARS-CoV-2 entry receptor, and critical appraisal of its role in acute lung injury. Biomed Pharmacother 2021; 136: 111193
• 30 Hoffmann M, Kleine-Weber H, Schroeder S. et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 2020; 181: 271-280 e278
• 31 Walls AC, Park YJ, Tortorici MA. et al. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell 2020; 181: 281-292.e286
• 32 Oz M, Lorke DE, Kabbani N. A comprehensive guide to the pharmacologic regulation of angiotensin converting enzyme 2 (ACE2), the SARS-CoV-2 entry receptor. Pharmacol Ther 2021; 221: 107750
• 33 Simoes e Silva AC, Silveira KD, Ferreira AJ. et al. ACE2, angiotensin-(1-7) and mas receptor axis in inflammation and fibrosis. Br J Pharmacol 2013; 169: 477-492
• 34 Swamy S, Koch CA, Hannah-Shmouni F. et al. Hypertension and COVID-19: updates from the era of vaccines and variants. J Clin Transl Endocrinol 2022; 27: 100285
• 35 Gomez-Zorita S, Milton-Laskibar I, Garcia-Arellano L. et al. An overview of adipose tissue ACE2 modulation by diet and obesity. Potential implications in COVID-19 infection and severity. Int J Mol Sci 2021; 22: 7975
• 36 Cauwenberghs N, Prunicki M, Sabovcik F. et al. Temporal changes in soluble angiotensin-converting enzyme 2 associated with metabolic health, body composition, and proteome dynamics during a weight loss diet intervention: a randomized trial with implications for the COVID-19 pandemic. Am J Clin Nutr 2021; 114: 1655-1665
• 37 Soll D, Beer F, Spranger L. et al. Effects of weight loss on adipose and muscular neuropilin 1 mRNA expression in obesity: potential implication in SARS-CoV-2 infections?. Obes Facts 2022; 15: 90-98
• 38 Shakartalla SB, Alhumaidi RB, Shammout ODA. et al. Dyslipidemia in breast cancer patients increases the risk of SAR-CoV-2 infection. Infect Genet Evol 2021; 92: 104883
• 39 Alketbi EH, Hamdy R, El-Kabalawy A. et al. Lipid-based therapies against SARS-CoV-2. infection. 2021; 31: e2214
• 40 Soliman S, Faris ME, Ratemi Z. et al. Switching host metabolism as an approach to dampen SARS-CoV-2 infection. Ann Nutr Metab 2020; 76: 297-303
• 41 Alzaabi MM, Hamdy R, Ashmawy NS. et al. Flavonoids are promising safe therapy against COVID-19. Phytochem Rev 2022; 21: 291-312
• 42 Russo L, Lumeng CN. Properties and functions of adipose tissue macrophages in obesity. Immunology 2018; 155: 407-417
• 43 Valencak TG, Osterrieder A, Schulz TJ. Sex matters: the effects of biological sex on adipose tissue biology and energy metabolism. Redox Biol 2017; 12: 806-813
• 44 Kott KA, Morel-Kopp MC, Vernon ST. et al. Association of global coagulation profiles with cardiovascular risk factors and atherosclerosis: a sex disaggregated analysis from the BioHEART-CT study. J Am Heart Assoc 2021; 10: e020604
• 45 Golzarand M, Hollis BW, Mirmiran P. et al. Vitamin D supplementation and body fat mass: a systematic review and meta-analysis. Eur J Clin Nutr 2018; 72: 1345-1357
• 46 Colleluori G, Graciotti L, Pesaresi M. et al. Visceral fat inflammation and fat embolism are associated with lung’s lipidic hyaline membranes in subjects with COVID-19. Int J Obes (Lond) 2022; 46: 1009-1017
• 47 Hoong CWS, Hussain I, Aravamudan VM. et al. Obesity is associated with poor Covid-19 outcomes: a systematic review and meta-analysis. Horm Metab Res 2021; 53: 85-93
• 48 Seidu S, Gillies C, Zaccardi F. et al. The impact of obesity on severe disease and mortality in people with SARS-CoV-2: a systematic review and meta-analysis. Endocrinol Diabetes Metab 2020; 4: e00176
• 49 Shekhar S, Wurth R, Kamilaris CDC. et al. Endocrine conditions and COVID-19. Horm Metab Res 2020; 52: 471-484
• 50 Ayres JS. A metabolic handbook for the COVID-19 pandemic. Nat Metab 2020; 2: 572-585
• 51 Kumada M, Kihara S, Ouchi N. et al. Adiponectin specifically increased tissue inhibitor of metalloproteinase-1 through interleukin-10 expression in human macrophages. Circulation 2004; 109: 2046-2049
• 52 Ohashi K, Parker JL, Ouchi N. et al. Adiponectin promotes macrophage polarization toward an anti-inflammatory phenotype. J Biol Chem 2010; 285: 6153-6160
• 53 Maier HE, Lopez R, Sanchez N. et al. Obesity increases the duration of influenza A virus shedding in adults. J Infect Dis 2018; 218: 1378-1382
• 54 Ryan PM, Caplice NM. Is adipose tissue a reservoir for viral spread, immune activation, and cytokine amplification in Coronavirus disease 2019?. Obesity 2020; 28: 1191-1194
• 55 Zickler M, Stanelle-Bertram S, Ehret S. et al. Replication of SARS-CoV-2 in adipose tissue determines organ and systemic lipid metabolism in hamsters and humans. Cell Metab 2022; 34: 1-2
• 56 Poma AM, Bonuccelli D, Giannini R. et al. COVID-19 autopsy cases: detection of virus in endocrine tissues. J Endocrinol Invest 2022; 45: 209-214
• 57 Thomas T, Stefanoni D, Reisz JA. et al. COVID-19 infection alters kynurenine and fatty acid metabolism, correlating with IL-6 levels and renal status. JCI Insight 2020; 5: e140327
• 58 Vasheghani M, Hessami Z, Rekabi M. et al. Evaluating possible mechanisms linking obesity to COVID-19: a narrative review. Obes Surg 2022; 32: 1689-1700
• 59 Boucher J, Kleinridders A, Kahn CR. Insulin receptor signaling in normal and insulin-resistant states. Cold Spring Harb Perspect Biol 2014; 6: a009191
• 60 Amin MN, Hussain MS, Sarwar MS. et al. How the association between obesity and inflammation may lead to insulin resistance and cancer. Diabetes Metab Syndr 2019; 13: 1213-1224
• 61 Turer AT, Khera A, Ayers CR. et al. Adipose tissue mass and location affect circulating adiponectin levels. Diabetologia 2011; 54: 2515
• 62 Diez JJ, Iglesias P. The role of the novel adipocyte-derived hormone adiponectin in human disease. Eur J Endocrinol 2003; 148: 293-300
• 63 Lasbleiz A, Gaborit B, Soghomonian A. et al. COVID-19 and obesity: role of ectopic visceral and epicardial adipose tissues in myocardial injury. Front Endocrinol (Lausanne) 2021; 12: 726967
• 64 Manca R, Bombillar F, Glomski C. et al. Obesity and immune system impairment: A global problem during the COVID-19 pandemic. Int J Risk Saf Med 2022; 33: 193-208
• 65 Seal A, Schaffner A, Phelan S. et al. COVID-19 pandemic and stay-at-home mandates promote weight gain in US adults. Obesity (Silver Spring) 2022; 30: 240-248
• 66 Cena H, Fiechtner L, Vincenti A. et al. COVID-19 pandemic as risk factors for excessive weight gain in pediatrics: the role of changes in nutrition behavior. A narrative review. Nutrients 2021; 13: 4255
• 67 Kiess W, Kirstein AS, Stein R. et al. Obesity after the Covid-19 pandemic and beyond. J Pediatr Endocrinol Metab 2022; 35: 135-138
• 68 Dun Y, Ripley-Gonzalez JW, Zhou N. et al. Weight gain in Chinese youth during a 4-month COVID-19 lockdown: a retrospective observational study. BMJ Open 2021; 11: e052451
• 69 Kang HM, Jeong DC, Suh BK. et al. The impact of the Coronavirus disease-2019 pandemic on childhood obesity and vitamin D status. J Korean Med Sci 2021; 36: e21
• 70 Miller L, Berber E, Sumbria D. et al. Controlling the burden of COVID-19 by manipulating host metabolism. Viral Immunol 2022; 35: 24-32
• 71 Milner JJ, Rebeles J, Dhungana S. et al. Obesity increases mortality and modulates the lung metabolome during pandemic H1N1 influenza virus infection in mice. J Immunol 2015; 194: 4846-4859
• 72 Martinson ML, Chang YL, Han WJ. et al. Child overweight and obesity in Shanghai, China: contextualizing Chinese socioeconomic and gender differences. Int J Behav Med 2018; 25: 141-149
• 73 Nogueira H, Costeira EPMM, Costa D. et al. The environment contribution to gender differences in childhood obesity and organized sports engagement. Am J Hum Biol 2020; 32: e23322
• 74 Shah B, Tombeau Cost K, Fuller A. et al. Sex and gender differences in childhood obesity: contributing to the research agenda. BMJ Nutr Prev Health 2020; 3: 387-390
• 75 Wu Q, Zhou L, Sun X. et al. Altered lipid metabolism in recovered SARS patients twelve years after infection. Sci Rep 2017; 7: 9110
• 76 Yang JK, Lin SS, Ji XJ. et al. Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes. Acta Diabetol 2010; 47: 193-199
• 77 Blomberg B, Mohn KG, Brokstad KA. et al. Long COVID in a prospective cohort of home-isolated patients. Nat Med 2021; 27: 1607-1613
• 78 Pavli A, Theodoridou M, Maltezou HC. Post-COVID syndrome: incidence, clinical spectrum, and challenges for primary healthcare professionals. Arch Med Res 2021; 52: 575-581
• 79 Tabacof L, Tosto-Mancuso J, Wood J. et al. Post-acute COVID-19 syndrome negatively impacts physical function, cognitive function, health-related quality of life, and participation. Am J Phys Med Rehabil 2022; 101: 48-52
• 80 Kim Y, Bitna H, Kim SW. et al. Post-acute COVID-19 syndrome in patients after 12 months from COVID-19 infection in Korea. BMC Infect Dis 2022; 22: 93
• 81 Nasserie T, Hittle M, Goodman SN. Assessment of the frequency and variety of persistent symptoms among patients with COVID-19: a systematic review. JAMA Netw Open 2021; 4: e2111417
• 82 Rogers JP, Chesney E, Oliver D. et al. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet. Psychiatry 2020; 7: 611-627
• 83 Khunti K, Davies MJ, Kosiborod MN. et al. Long COVID – metabolic risk factors and novel therapeutic management. Nat Rev Endocrinol 2021; 17: 379-380
• 84 Dagan N, Barda N, Kepten E. et al. BNT162b2 mRNA Covid-19 vaccine in a nationwide mass vaccination setting. N Engl J Med 2021; 384: 1412-1423
• 85 Hanckova M, Betakova T. Pandemics of the 21st century: the risk factor for obese people. Viruses 2021; 14: 25
• 86 Juthani PV, Gupta A, Borges KA. et al. Hospitalisation among vaccine breakthrough COVID-19 infections. Lancet Infect Dis 2021; 21: 1485-1486
• 87 Stefan N. Metabolic disorders, COVID-19 and vaccine-breakthrough infections. Nat Rev Endocrinol 2022; 18: 75-76
• 88 Rahman S, Rahman MM, Miah M. et al. COVID-19 reinfections among naturally infected and vaccinated individuals. Sci Rep 2022; 12: 1438
• 89 Saliba K, Cuschieri S. Amidst the COVID-19 pandemic childhood obesity is still an epidemic-spotlight on obesity’s multifactorial determinants. Health Sci Rev (Oxf) 2021; 1: 100006
• 90 Petrie JR, Boyle JG, Ali K. et al. A post COVID-19 ‘Marshall Plan’ for type 2 diabetes. Diabet Med 2021; 38: e14439